Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2010 7
2011 2
2012 3
2013 2
2014 4
2015 5
2016 3
2017 3
2018 4
2019 4
2020 5
2021 2
2022 2
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
CD47 promotes peripheral T cell survival by preventing dendritic cell-mediated T cell necroptosis.
Komori S, Saito Y, Nishimura T, Respatika D, Endoh H, Yoshida H, Sugihara R, Iida-Norita R, Afroj T, Takai T, Oduori OS, Nitta E, Kotani T, Murata Y, Kaneko Y, Nitta R, Ohnishi H, Matozaki T. Komori S, et al. Among authors: kotani t. Proc Natl Acad Sci U S A. 2023 Aug 15;120(33):e2304943120. doi: 10.1073/pnas.2304943120. Epub 2023 Aug 7. Proc Natl Acad Sci U S A. 2023. PMID: 37549290 Free PMC article.
Blockade of CD47 or SIRPα: a new cancer immunotherapy.
Murata Y, Saito Y, Kotani T, Matozaki T. Murata Y, et al. Among authors: kotani t. Expert Opin Ther Targets. 2020 Oct;24(10):945-951. doi: 10.1080/14728222.2020.1811855. Epub 2020 Sep 2. Expert Opin Ther Targets. 2020. PMID: 32799682
LAT1 expression influences Paneth cell number and tumor development in ApcMin/+ mice.
Sui Y, Hoshi N, Ohgaki R, Kong L, Yoshida R, Okamoto N, Kinoshita M, Miyazaki H, Ku Y, Tokunaga E, Ito Y, Watanabe D, Ooi M, Shinohara M, Sasaki K, Zen Y, Kotani T, Matozaki T, Tian Z, Kanai Y, Kodama Y. Sui Y, et al. Among authors: kotani t. J Gastroenterol. 2023 May;58(5):444-457. doi: 10.1007/s00535-023-01960-5. Epub 2023 Feb 5. J Gastroenterol. 2023. PMID: 36739585 Free PMC article.
Targeting of SIRPα as a potential therapy for Langerhans cell histiocytosis.
Okamoto T, Murata Y, Hasegawa D, Yoshida M, Tanaka D, Ueda T, Hazama D, Oduori OS, Komori S, Takai T, Saito Y, Kotani T, Kosaka Y, Maniwa Y, Matozaki T. Okamoto T, et al. Among authors: kotani t. Cancer Sci. 2023 May;114(5):1871-1881. doi: 10.1111/cas.15758. Epub 2023 Feb 27. Cancer Sci. 2023. PMID: 36788737 Free PMC article.
Future therapeutic potential of SAP-1 in inflammatory bowel diseases.
Kotani T, Murata Y, Saito Y, Matozaki T. Kotani T, et al. Expert Rev Gastroenterol Hepatol. 2016 Dec;10(12):1313-1315. doi: 10.1080/17474124.2016.1245144. Epub 2016 Oct 19. Expert Rev Gastroenterol Hepatol. 2016. PMID: 27705005 No abstract available.
Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models.
Saito Y, Iida-Norita R, Afroj T, Refaat A, Hazama D, Komori S, Ohata S, Takai T, Oduori OS, Kotani T, Funakoshi Y, Koma YI, Murata Y, Yakushijin K, Matsuoka H, Minami H, Yokozaki H, Manz MG, Matozaki T. Saito Y, et al. Among authors: kotani t. Front Immunol. 2023 Dec 14;14:1294814. doi: 10.3389/fimmu.2023.1294814. eCollection 2023. Front Immunol. 2023. PMID: 38162643 Free PMC article.
50 results